BeStock  
Markets › Compare › EWTX vs ERAS

EWTX vs ERAS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
EWTX · Edgewise Therapeutics$39.91 ▼ 3.07%
ERAS · Erasca$13.61 ▼ 4.29%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

48241433626819Nov 24, '25May 26, '26Nov 20, '26
  • EWTX +70.0%
  • ERAS +370.9%

Head to head

MetricEWTXERAS
Price$39.91$13.61
Change today▼ 3.07%▼ 4.29%
Market cap$4.37B$4.78B
Return, 3 months-10.8%-22.7%
Return, year to date+60.8%+265.9%
Return, 1 year+76.0%+366.1%
P/E (TTM)4.8–
P/B2.75.2
P/E percentile vs own 5y100th12th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)+2,967.6%-67.7%
Gross margin––
Operating margin––
Net margin––
Return on equity92.1%-48.7%
Analyst target vs. price+47.6%+81.3%
Analyst buy share100%67%
RSI (14)4443
30-day volatility65.9%81.2%
Max drawdown, 1 year-25.0%-59.5%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ERAS is the largest of the group by market value.
  • ERAS has returned the most over the past year.
  • EWTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top